Term Name: | 2CN115 |
---|---|
Synonyms: | (3-ethynylphenyl)methyl N-[(1S)-1-{[(1E,3S)-5-carbamoyl-1-methanesulfonylpent-1-en-3-yl]carbamoyl}-3-methylbutyl]carbamate, AL-Cbz-Leu-Gln-VS, N-[(1E,3S)-6-amino-1-(methanesulfonyl)-6-oxohex-1-en-3-yl]-N(2)-{[(3-ethynylphenyl)methoxy]carbonyl}-L-leucinamide, N-[(1E,3S)-6-amino-1-(methylsulfonyl)-6-oxohex-1-en-3-yl]-N(2)-{[(3-ethynylbenzyl)oxy]carbonyl}-L-leucinamide |
Definition: | An oligopeptide that is N-[(1E,3S)-6-amino-1-(methanesulfonyl)-6-oxohex-1-en-3-yl]-N(2)-carboxy-L-leucinamide in which the carboxy group is protected by a (3-ethynylphenyl)methyl group. It is a SARS-CoV-2 Nsp5 main protease inhibitor that inhibits SARS-CoV-2 replication. |
Ontology: | ChEBI [CHEBI:180646] ( EBI ) |